Company Profile

AmpliPhi Biosciences Corporation (AKA: Targeted Genetics Corporation~RGene Therapeutics Inc)
Profile last edited on: 12/2/2023      CAGE: -----      UEI: ----------

Business Identifier: Gene therapy products to prevent and to treat acquired and inherited diseases
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1100 Olive Way Suite 100
Seattle, WA 98101
   (206) 623-7612
Location: Single
Congr. District: 07
County: King

Public Profile

Currently there is no description available for this company.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1997 2 NIH $799,623
Project Title: Development of an AAV CFTR Vector Production System
1996 1 NIH $100,000
Project Title: Integrase Mediated Gene Delivery
1996 1 NIH $98,270
Project Title: ELA Gene Therapy In Ovarian And Breast Cancer BB IND 6178

Key People / Management

  Susan Robinson -- President

  Barrie J Carter -- Executive VP & CSO

  Robert L De Jager

  H Stewart Parker -- Former President and Chief Executive Officer

  Anna M Skalka